Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

Clinical trial NCT07046806 · RECRUITING

Trial details

NCT number: NCT07046806
Sponsor: Institute for Asthma and Allergy
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)Angioedema Bradykinin-mediated Angioedema C1 Inhibitor Deficiency

Start date: 2025-03-10
Primary completion: 2026-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.